ED
RIVN icon

Exane Derivatives’s Rivian RIVN Stock Holding History

Exane Derivatives’s Portfolio RIVN Stock Details RIVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$28K Buy
+1,088
New +$34K 0.02% 350

Other funds holding RIVN

ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Exane Derivatives's RIVN Position: Q2 2022 in Review

Exane Derivatives opened a new position in Rivian (RIVN) in Q2 2022: 1,088 shares worth $28K. The stake represents 0.02% of the portfolio and ranks #350 among its holdings.

556 funds tracked by Wall St. Rank hold RIVN as of Q2 2022.

  • Exane Derivatives held 1,088 shares of Rivian worth $28K as of Q2 2022.
  • Rivian was a new Exane Derivatives position in Q2 2022.
  • Rivian made up 0.02% of Exane Derivatives's portfolio in Q2 2022, its #350 holding.
  • 556 funds tracked by Wall St. Rank held Rivian as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.